Skip to content
★ Sign in to follow
EJ

Edward J. Hejlek

Executive
Total declarations
28
Companies
2
▲ Purchases (3 ops.)
€362k
▼ Sales (7 ops.)
€1.5M

Latest filing published 08 Nov 2022 for Enovix Corp, €12k.

Filing timeline

BuySale
Edward J. Hejlek

Insider track record

Disclosed buys
3
Disclosed sells
7
T+90 hit rate
100%
T+90 mean return
+123.1%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Edward J. Hejlek: trading record in brief

Filings by Edward J. Hejlek span 2 companies, the busiest being Tricida, Inc. and Enovix Corp. Between 2 July 2018 and 6 November 2022, the trades on record add up to 28 filings.

Both buying and selling appear: 3 purchases worth €362k, against 7 sales worth €1.5M. The net balance comes to €1.1M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 10 share grants and 8 option exercises. 2022 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €87k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 8 November 2022: a share grant of €12k, in Enovix Corp. The most recent open-market purchase was published on 16 May 2022, 1,638 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Edward J. Hejlek

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ◆
    See RemarksExecutivesEnovix Corp
    11,546 USD22SEC
    1,075 shares@ US$10.744.7% of flowCommon StockSEC:0001828318-22-000080:0
  • ◆
    See RemarksExecutivesEnovix Corp
    15,404 USD27SEC
    1,069 shares@ US$14.416.0% of flowCommon StockSEC:0001828318-22-000055:0
  • ◆
    See RemarksExecutivesEnovix Corp
    9,088 USD26SEC
    1,047 shares@ US$8.683.5% of flowCommon StockSEC:0001209191-22-041674:0
  • ◆
    See RemarksExecutivesEnovix Corp
    0SEC
    59,656 shares0Common StockSEC:0001209191-22-035255:0
  • ◆
    See RemarksExecutivesEnovix Corp
    8,453 USD10SEC
    908 shares@ US$9.314.2% of flowCommon StockSEC:0001209191-22-035249:0
  • ◆
    See RemarksExecutivesEnovix Corp
    0SEC
    2,214 shares0Common StockSEC:0001209191-22-031749:0
  • ▲
    See RemarksExecutivesEnovix Corp
    89,900 USD28SEC
    10,000 shares@ US$8.9945.3% of flowCommon StockSEC:0001209191-22-029158:0
    Canonical exit: 11 Aug 2022 (T+90)
  • ▲
    See RemarksExecutivesEnovix Corp
    71,500 USD24SEC
    5,000 shares@ US$14.3031.8% of flowCommon StockSEC:0001209191-21-051179:0
    Canonical exit: 10 Nov 2021 (T+90)
  • ◆
    See RemarksExecutivesEnovix Corp
    0SEC
    156,921 sharesCommon StockSEC:0001209191-21-047046:0

9 of 9 declarations